$CB

Keogh John W sold $7.4M of CB

Keogh John W (President &COO) sold 23,000 shares of Chubb Ltd (CB) at an average of $321.51 ($321.45–$321.95, $7.39M total) across 2 trades on 2026-05-27.

Original reporting
SEC EDGAR · Keogh John W
Published May 29, 2026, 8:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 3:47 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CB
Bearish
medium confidence
Mentioned
$CB
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CBBearishLow
01

Why it matters

The transaction is the first public disclosure of this insider activity, providing new information for traders.

02

Market read

Insider sell adds modest negative pressure to CB; may influence short‑term sentiment in the insurance sector.

03

What to watch

No accompanying earnings or guidance change; market may already price the sale.

Relevance 6/10Novelty 7/10Timing: today

Background

SEC Form 4 filing discloses a direct open‑market sale by Chubb's President & COO.

Company-level read

Ticker impact

$CBBearishMedium confidence
Context

President & COO John W. Keogh sold 23,000 Chubb shares for $7.4 M on May 27, 2026.

Expected impact

likely downward pressure as the market prices in the insider sell.

Evidence & confidence

The sale size ($7.4 M) is material for a large‑cap insurer and the insider holds a senior role.

Market effects

May prompt scrutiny of other insurer insider holdings.

Limited to US insurance sector.

Minimal beyond Chubb and peers.

Counterpoint

The sale could be a routine portfolio rebalancing, not a bearish signal.

Key entities

  • Chubb Ltd

    Large‑cap property‑casualty insurer (ticker CB).

  • John W. Keogh

    President & COO of Chubb, insider seller.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CBMed

Fed hikes again - an AI-Picked insurer is still cashing in

The Federal Reserve raised rates, impacting markets. Investing.com's AI models show varied portfolio performance. Chubb (CB) is benefiting from higher rates, with a 1.13% monthly gain, due to its Treasury investments. CB's earnings beat estimates, and it trades at a low forward P/E. The Fed's decision is affecting sectors differently.

$CBMed

Is Wall Street Bullish or Bearish on Chubb Limited Stock?

Chubb Limited (CB), a global insurer, has seen its stock rise 26% over the past year, outpacing the S&P 500. In 2026, it gained 10.2%, underperforming the index. CB offers a 1.20% dividend yield and has increased payouts for 18 years. Analysts expect 10.7% EPS growth this year. The consensus rating is 'Moderate Buy' with a mean price target of $369.36, suggesting 6.1% upside.

$CBMed

What Chubb (CB)'s Earnings Beat and Completed Buyback Mean For Shareholders

Chubb Limited (CB) reported Q2 2026 earnings above analyst estimates, citing higher underwriting and investment income and 3.6% net premium written growth across Property & Casualty and Life. The company also completed a US$4.45 billion multi-year buyback totaling 14,811,112 shares. Chubb Tempest Re named James Wixtead Executive Chairman and Michael O’Donnell President.